Chronic Hepatitis C in HIV-Infected Patients: Those Who More Need Therapy are Those Who Respond Less

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 57-68

Bentham Science Publishers

Access to resources Recommend Favorite

C‐reactive protein as a predictor of low trough infliximab concentrations in patients who lose response to infliximab

By  

Journal of Digestive Diseases, Vol. 18, Iss. 12, 2017-12 ,pp. : 678-683

John Wiley & Sons Inc

Access to resources Recommend Favorite

For patients with hepatitis C virus (HCV) infection who respond rapidly to peginterferon-α-2a, 8 weeks of therapy is as effective as a 24 weeks

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

A Proposal for a Pharmacokinetic Interaction Significance Classification System (PISCS) Based on Predicted Drug Exposure Changes and Its Potential Application to Alert Classifications in Product Labelling

By Hisaka Akihiro  

Clinical Pharmacokinetics, Vol. 48, Iss. 10, 2009-10 ,pp. : 653-666

Adis International

Access to resources Recommend Favorite

Interferon-alfacon-1 shows efficacy in patients with chronic hepatitis C who have not responded to, or relapsed after, prior therapy with IFN- -2b plus ribavirin

By  

Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite